533 related articles for article (PubMed ID: 17565629)
1. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
Farrell GC; Chitturi S; Lau GK; Sollano JD;
J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
[No Abstract] [Full Text] [Related]
2. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
[TBL] [Abstract][Full Text] [Related]
3. How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
[TBL] [Abstract][Full Text] [Related]
4. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease guidelines: an Asian perspective.
Ishii H; Kajihara M
J Gastroenterol Hepatol; 2007 Jun; 22(6):769-70. PubMed ID: 17565626
[No Abstract] [Full Text] [Related]
6. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
Chitturi S; Farrell GC; George J
J Gastroenterol Hepatol; 2004 Apr; 19(4):368-74. PubMed ID: 15012772
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
Tarantino G; Saldalamacchia G; Conca P; Arena A
J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.
Karlas T; Wiegand J; Berg T
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):195-208. PubMed ID: 23731881
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of non-alcoholic fatty liver disease in China.
Fan JG; Farrell GC
J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
[TBL] [Abstract][Full Text] [Related]
12. Changing disease trends in the Asia-Pacific.
Tan DA
Climacteric; 2011 Oct; 14(5):529-34. PubMed ID: 21395451
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.
Lebovics E; Rubin J
Diabetes Metab Res Rev; 2011 Jul; 27(5):419-24. PubMed ID: 21425426
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
Rafiq N; Younossi ZM
Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan.
Okanoue T; Umemura A; Yasui K; Itoh Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():153-62. PubMed ID: 21199527
[TBL] [Abstract][Full Text] [Related]
16. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
17. Silent non-alcoholic fatty liver disease-a clinical-histological study.
Sorrentino P; Tarantino G; Conca P; Perrella A; Terracciano ML; Vecchione R; Gargiulo G; Gennarelli N; Lobello R
J Hepatol; 2004 Nov; 41(5):751-7. PubMed ID: 15519647
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
19. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].
Tilg H
Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453
[No Abstract] [Full Text] [Related]
20. Hypertension and fatty liver: guilty by association?
Brookes MJ; Cooper BT
J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
